Research Medicine Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 2.00 Cr
as on 17-06-2024
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.07 Cr
as on 17-06-2024
- Satisfied Charges ₹ 1.31 Cr
as on 17-06-2024
- Revenue 5.06%
(FY 2022)
- Profit 13.23%
(FY 2022)
- Ebitda 13.80%
(FY 2022)
- Net Worth 115.99%
(FY 2022)
- Total Assets 5.83%
(FY 2022)
About Research Medicine
The Corporate was formerly known as Srishti Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.07 Cr. The company has closed loans amounting to ₹1.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chander Mohan and Manoj Kalra serve as directors at the Company.
- CIN/LLPIN
U24239DL2002PTC117163
- Company No.
117163
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Rohini, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Research Medicine?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Mohan  | Director | 27-Sep-2002 | Current |
| Manoj Kalra | Director | 27-Sep-2002 | Current |
Financial Performance of Research Medicine.
Research Medicine Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.06% increase. The company also saw a substantial improvement in profitability, with a 13.23% increase in profit. The company's net worth Soared by an impressive increase of 115.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Research Medicine?
In 2022, Research Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemistaa India Private LimitedActive 12 years 11 monthsChander Mohan and Manoj Kalra are mutual person
- Bhagwan Devi Pharmaceuticals Private LimitedActive 8 years 10 months
Chander Mohan and Manoj Kalra are mutual person
- Rescare Pharmaceuticals Private LimitedActive 8 years 1 month
Chander Mohan and Manoj Kalra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 08 Nov 2021 | ₹1.20 M | Open |
Canara Bank Creation Date: 26 Jul 2016 | ₹1.95 Cr | Open |
Bank Of Baroda Creation Date: 16 Jan 2013 | ₹8.10 M | Satisfied |
How Many Employees Work at Research Medicine?
Unlock and access historical data on people associated with Research Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Research Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Research Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
